A detailed history of Blair William & CO transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Blair William & CO holds 12,649 shares of TAK stock, worth $168,990. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,649
Previous 11,872 6.54%
Holding current value
$168,990
Previous $169,000 3.55%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$13.89 - $15.04 $10,792 - $11,686
777 Added 6.54%
12,649 $175,000
Q4 2023

Feb 12, 2024

BUY
$13.36 - $15.43 $2,712 - $3,132
203 Added 1.74%
11,872 $169,000
Q2 2023

Aug 11, 2023

SELL
$15.57 - $17.11 $856 - $941
-55 Reduced 0.47%
11,669 $183,000
Q1 2023

May 12, 2023

SELL
$15.28 - $16.48 $840 - $906
-55 Reduced 0.47%
11,724 $193,000
Q4 2022

Feb 10, 2023

BUY
$12.42 - $15.62 $37 - $46
3 Added 0.03%
11,779 $183,000
Q3 2022

Nov 09, 2022

BUY
$12.8 - $28.65 $10,009 - $22,404
782 Added 7.11%
11,776 $153,000
Q2 2022

Aug 10, 2022

SELL
$13.12 - $15.03 $13,526 - $15,495
-1,031 Reduced 8.57%
10,994 $154,000
Q1 2022

May 13, 2022

BUY
$13.54 - $15.35 $5,280 - $5,986
390 Added 3.35%
12,025 $172,000
Q4 2021

Feb 14, 2022

SELL
$13.17 - $16.4 $16,949 - $21,106
-1,287 Reduced 9.96%
11,635 $159,000
Q3 2021

Nov 12, 2021

BUY
$16.3 - $17.26 $1,564 - $1,656
96 Added 0.75%
12,922 $212,000
Q2 2021

Aug 12, 2021

SELL
$16.55 - $18.64 $7,000 - $7,884
-423 Reduced 3.19%
12,826 $216,000
Q1 2021

May 13, 2021

BUY
$16.71 - $19.9 $5,614 - $6,686
336 Added 2.6%
13,249 $242,000
Q4 2020

Feb 09, 2021

SELL
$15.39 - $18.97 $22,238 - $27,411
-1,445 Reduced 10.06%
12,913 $235,000
Q3 2020

Nov 06, 2020

SELL
$17.1 - $19.19 $9,131 - $10,247
-534 Reduced 3.59%
14,358 $256,000
Q2 2020

Aug 12, 2020

BUY
$14.59 - $19.5 $12,839 - $17,160
880 Added 6.28%
14,892 $267,000
Q1 2020

May 11, 2020

BUY
$13.02 - $20.31 $6,822 - $10,642
524 Added 3.88%
14,012 $213,000
Q4 2019

Feb 13, 2020

SELL
$16.88 - $20.83 $60,025 - $74,071
-3,556 Reduced 20.86%
13,488 $266,000
Q3 2019

Nov 12, 2019

BUY
$16.15 - $17.99 $26,808 - $29,863
1,660 Added 10.79%
17,044 $293,000
Q2 2019

Aug 13, 2019

SELL
$16.58 - $20.49 $13,363 - $16,514
-806 Reduced 4.98%
15,384 $272,000
Q1 2019

May 14, 2019

BUY
$16.7 - $21.52 $270,373 - $348,408
16,190 New
16,190 $330,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $41.5B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.